ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL)

Clinical trials for ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL) explained in plain language.

Never miss a new study

Get alerted when new ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL) trials appear

Sign up with your email to follow new studies for ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo offers hope for tough leukemia

Disease control Ongoing

This study tests a new combination of drugs (PD-1 inhibitor, venetoclax, and chemotherapy) in 40 adults with T-cell leukemia that has come back or not responded to standard treatment. The goal is to see if this approach can improve remission rates and help patients get to a stem …

Matched conditions: ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL)

Phase: PHASE3 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control

Last updated May 01, 2026 15:57 UTC

ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL)

Get alerted when new ACUTE T LYMPHOBLASTIC LEUKEMIA (T-ALL) trials appear

New combo offers hope for tough leukemia